Actelion, Barry Callebaut, Credit Suisse: Swiss Equity Preview
Stock Chart for Actelion Ltd (ATLN)
The following is a list of companies whose shares may have unusual price changes in Zurich. Stock symbols are in parentheses after company names. Share prices are from the last close.
The Swiss Market Index of the biggest and most actively traded companies rose 1.4 percent to 6,534.84 in Zurich. The broader Swiss Performance Index gained 1.5 percent, to 5,866.99.
Actelion Ltd. (ATLN VX): The chief executive officer of Switzerland’s largest biotechnology company, Jean-Paul Clozel, said he thinks the company will be independent in one year. The shares declined 1.7 percent to 51.50 francs.
Barry Callebaut AG (BARN SW): The world’s largest maker of bulk chocolate said first-quarter revenue rose 4.9 percent to 1.52 billion Swiss francs ($1.56 billion). The shares dropped 1.3 percent to 738 francs.
Credit Suisse Group AG (CSGN VX): Switzerland’s second- biggest bank sold $2 billion of three-year fixed- and floating- rate debt yesterday, according to data compiled by Bloomberg. The shares rose 1.9 percent to 40.85 francs.
Kaba Holding AG (KABN SW): Riet Cadonau will replace Rudolf Weber as chief executive of the provider of electronic security systems beginning in July. The shares added 1.2 percent to 386 francs.
Kuehne + Nagel International AG (KNIN) VX: The 120-year-old shipping company was downgraded by HSBC Holdings to “underweight” from “neutral.” The shares gained 2.5 percent to 134.90 francs.
Nobel Biocare Holding AG (NOBN VX): The world’s largest maker of dental implants’ Procera business is improving, Chairman Heino von Prondzynski told Finanz & Wirtschaft in an interview. The shares advanced 2.3 percent to 18.76 francs.
SGS SA (SGSN VX): The world’s biggest inspection company acquired LGC Group’s chemical characterization business. The shares rose 2 percent to 1,575 francs.
Sika AG (SIK SW): UBS AG upgraded the No. 1 maker of chemicals for the construction industry to “buy” from “neutral.” The shares were unchanged at 2,048 francs.
To contact the reporter on this story: Giles Broom in Zurich at firstname.lastname@example.org.
To contact the editor responsible for this story: David Merritt at email@example.com.
Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.